pyrazines has been researched along with Schizophrenia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jayathilake, K; Lee, MA; Meltzer, HY; Sim, MY | 1 |
Alcázar, J; Alonso de Diego, SA; Bartolomé-Nebreda, JM; Bridges, TM; Conde-Ceide, S; Conn, PJ; Daniels, JS; Jones, CK; Lavreysen, H; Lindsley, CW; López, S; Macdonald, GJ; Mackie, C; Martín-Martín, ML; Martínez-Viturro, CM; Niswender, CM; Pena, MA; Stauffer, SR; Steckler, T; Tong, HM | 1 |
Cilia, J; Cluderay, JE; Dawson, LA; Gartlon, JE; Jennings, CA; Jones, DN; Lacroix, LP; Medhurst, AD; Reavill, C; Rourke, C; Southam, E; Wilson, DM; Woolley, ML | 1 |
Apte, JS; Desai, NK; Doongaji, DR; Parikh, RM; Paul, T; Satoskar, RS; Sheth, AS; Upadhaya, AK; Vahora, SA | 1 |
Maes, M; Meltzer, HY; Thompson, PA | 1 |
Bastani, B; Friedman, L; Lee, HS; Meltzer, HY; Ramirez, L | 1 |
Apte, JS; Desai, AB; Doongaji, DR; Satoskar, RS; Shah, BR; Sheth, AS | 1 |
3 trial(s) available for pyrazines and Schizophrenia
Article | Year |
---|---|
Effect of the placebo control condition in neuroendocrine challenge studies.
Topics: 5-Hydroxytryptophan; Antipsychotic Agents; Apomorphine; Bias; Buspirone; Data Interpretation, Statistical; Depressive Disorder; Female; Fenfluramine; Growth Hormone; Humans; Hydrocortisone; Male; Prolactin; Pyrazines; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists | 1994 |
Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.
Topics: Adult; Body Temperature Regulation; Female; Humans; Male; Psychiatric Status Rating Scales; Pyrazines; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 1992 |
Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Pyrazines; Random Allocation; Schizophrenia; Trifluoperazine | 1989 |
4 other study(ies) available for pyrazines and Schizophrenia
Article | Year |
---|---|
Decreased serotonin2C receptor responses in male patients with schizophrenia.
Topics: Adult; Body Temperature Regulation; Case-Control Studies; Female; Humans; Hydrocortisone; Male; Middle Aged; Psychopathology; Pyrazines; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Serotonin; Serotonin Receptor Agonists; Severity of Illness Index | 2015 |
Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; HEK293 Cells; Humans; Male; Pyrazines; Pyrazoles; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Schizophrenia | 2016 |
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Dose-Response Relationship, Drug; Histamine Antagonists; Hyperkinesis; Male; Memory; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Recognition, Psychology; Schizophrenia; Social Isolation | 2009 |
Clinical evaluation of centbutindole as an anti-psychotic agent.
Topics: Adult; Antipsychotic Agents; Drug Evaluation; Humans; Male; Psychiatric Status Rating Scales; Pyrazines; Schizophrenia | 1983 |